<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39254484</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0300-0729</ISSN><JournalIssue CitedMedium="Print"><PubDate><Year>2024</Year><Month>Sep</Month><Day>10</Day></PubDate></JournalIssue><Title>Rhinology</Title><ISOAbbreviation>Rhinology</ISOAbbreviation></Journal><ArticleTitle>SNOT-22 in general population, a Spanish cohort study with an updated meta-analysis.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.4193/Rhin24.233</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Olfactory loss (OL) has emerged as one of the most prevalent and debilitating symptoms of SARS-CoV-2 infection and long-COVID-19. The present prospective observational study aimed to evaluate the efficacy of olfactory training (OT) on orthonasal and retronasal olfactory function in a cohort of individuals with persistent post-COVID-19 OL.</AbstractText><AbstractText Label="METHODOLOGY" NlmCategory="METHODS">Participants with post-COVID-19 olfactory impairment underwent 4 months of OT, self-assessing their smell perception and undergoing comprehensive psychophysical evaluation of orthonasal and retronasal olfaction at baseline and after training. Orthonasal olfactory function was assessed using the extended Sniffin' Sticks test battery. Retronasal olfactory function was tested with powdered aromas.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 114 participants with post-COVID-19 olfactory loss, adherence to OT was 60%. In adherents, the average increase in composite TDI score was 6.0 points compared to 2.6 points in non-adherents. Fifty-seven percent of adherent participants achieved a clinically significant improvement in TDI score (&#x2265;5.5 points), compared to 22% of non-adherents. In retronasal olfactory identification, 56% of adherents achieved a clinically significant improvement (&#x2265;4 points), compared to 16% of non-adherents.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Adherence to a 4-month OT regimen can yield clinically meaningful improvements in both orthonasal and retronasal olfactory function among individuals with persistent post-COVID-19 olfactory dysfunction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pi&#xf1;eros-Garc&#xed;a</LastName><ForeName>L N</ForeName><Initials>LN</Initials><AffiliationInfo><Affiliation>Rhinology and Skull Base Unit, Otorhinolaryngology Department, Hospital Cl&#xed;nic de Barcelona, IDIBAPS, Universitat de Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez-S&#xe1;nchez</LastName><ForeName>N I</ForeName><Initials>NI</Initials><AffiliationInfo><Affiliation>Rhinology and Skull Base Unit, Otorhinolaryngology Department, Hospital Cl&#xed;nic de Barcelona, IDIBAPS, Universitat de Barcelona, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Calvo-Henrique</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Otorhinolaryngology Department, Hospital Complex and University of Santiago de Compostela, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Young-Otolaryngologists of the International Federations of Oto-rhino-laryngological Societies (YO-IFOS) study group.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Research in Airway Diseases, IDIS-Santiago de Compostela, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rojas-Lechuga</LastName><ForeName>M J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Rhinology and Skull Base Unit, Otorhinolaryngology Department, Hospital Cl&#xed;nic de Barcelona, IDIBAPS, Universitat de Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hopkins</LastName><ForeName>C</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Otorhinolaryngology Department, Guy's Hospital, London, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mullol</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Rhinology and Skull Base Unit, Otorhinolaryngology Department, Hospital Cl&#xed;nic de Barcelona, IDIBAPS, Universitat de Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alobid</LastName><ForeName>I</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Rhinology and Skull Base Unit, Otorhinolaryngology Department, Hospital Cl&#xed;nic de Barcelona, IDIBAPS, Universitat de Barcelona, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Centro de Investigaci&#xf3;n Biom&#xe9;dica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Netherlands</Country><MedlineTA>Rhinology</MedlineTA><NlmUniqueID>0347242</NlmUniqueID><ISSNLinking>0300-0729</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>12</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>10</Day><Hour>10</Hour><Minute>3</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39254484</ArticleId><ArticleId IdType="doi">10.4193/Rhin24.233</ArticleId><ArticleId IdType="pii">3208</ArticleId></ArticleIdList></PubmedData></PubmedArticle></PubmedArticleSet>